HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian Chi Kei Wong Selected Research

BNT162 Vaccine

12/2022Lack of inflammatory bowel disease flare-up following two-dose BNT162b2 vaccine: a population-based cohort study.
12/2022Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study.
11/2022Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines.
9/2022Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
8/2022Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study.
6/2022mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
4/2022Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study.
3/2022Comparing self-reported reactogenicity between adolescents and adults following the use of BNT162b2 (Pfizer-BioNTech) messenger RNA COVID-19 vaccine: a prospective cohort study.
1/2022Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
1/2022Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian Chi Kei Wong Research Topics

Disease

17COVID-19
11/2022 - 01/2021
7Neoplasms (Cancer)
05/2022 - 10/2014
5Type 2 Diabetes Mellitus (MODY)
11/2021 - 11/2018
4Myocarditis (Carditis)
12/2022 - 01/2022
4Infections
05/2022 - 01/2021
4Atrial Fibrillation
02/2022 - 04/2021
4Heart Failure
01/2022 - 01/2020
3Bell Palsy (Bell's Palsy)
06/2022 - 01/2022
3Peripheral Vascular Diseases (Peripheral Vascular Disease)
05/2021 - 01/2020
2Pericarditis
09/2022 - 01/2022
2Stroke (Strokes)
02/2022 - 04/2021
2Anaphylaxis (Anaphylactic Shock)
01/2022 - 01/2022
2Myocardial Infarction
01/2022 - 07/2021
2Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2021 - 07/2021
2Myocardial Ischemia (Ischemic Heart Diseases)
05/2021 - 04/2021
2Dementia (Dementias)
05/2021 - 04/2021
2Diabetes Mellitus
05/2021 - 04/2021
2Cardiovascular Diseases (Cardiovascular Disease)
11/2020 - 01/2020
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2022
1Hemorrhagic Stroke
08/2022
1Neoplasm Metastasis (Metastasis)
05/2022
1Prostatic Neoplasms (Prostate Cancer)
05/2022
1Herpes Zoster
04/2022
1Breakthrough Pain
02/2022
1Lung Neoplasms (Lung Cancer)
02/2022
1Chronic Disease (Chronic Diseases)
01/2022
1Hypothyroidism
01/2022
1Thromboembolism
01/2022
1Thrombocytopenia (Thrombopenia)
01/2022
1Leukopenia
01/2022
1Neutropenia
01/2022
1Arthritis (Polyarthritis)
01/2022
1Rheumatoid Arthritis
01/2022
1Cardiac Arrhythmias (Arrythmia)
11/2021
1Hypersensitivity (Allergy)
10/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2021
1Meningitis
10/2021
1Osteoporosis
05/2021
1Inflammation (Inflammations)
05/2021
1Diabetes Complications
05/2021
1Hypertension (High Blood Pressure)
04/2021
1Liver Diseases (Liver Disease)
04/2021
1Hemorrhage
04/2021

Drug/Important Bio-Agent (IBA)

16BNT162 VaccineIBA
12/2022 - 01/2022
11sinovac COVID-19 vaccineIBA
11/2022 - 01/2022
10VaccinesIBA
12/2022 - 01/2022
8COVID-19 VaccinesIBA
12/2022 - 01/2022
8Messenger RNA (mRNA)IBA
12/2022 - 01/2022
5insulin receptor-related receptor (IRR)IBA
12/2022 - 01/2022
4LipidsIBA
11/2021 - 01/2021
3SodiumIBA
02/2022 - 04/2021
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 04/2021
3Pharmaceutical PreparationsIBA
10/2021 - 10/2011
3CholesterolIBA
07/2021 - 01/2021
3Hypoglycemic Agents (Hypoglycemics)IBA
05/2021 - 11/2018
3CreatinineIBA
04/2021 - 01/2020
3HDL CholesterolIBA
04/2021 - 01/2021
2Pamidronate (Aredia)FDA LinkGeneric
05/2022 - 02/2022
2DenosumabFDA Link
05/2022 - 02/2022
2Zoledronic Acid (Zometa)FDA Link
05/2022 - 02/2022
2AlbuminsIBA
04/2021 - 01/2021
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 01/2021
2Angiotensin Receptor AntagonistsIBA
01/2021 - 01/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2022
1Diphosphonates (Bisphosphonates)IBA
05/2022
1atezolizumabIBA
03/2022
1pembrolizumabIBA
03/2022
1NivolumabIBA
03/2022
1Immune Checkpoint InhibitorsIBA
03/2022
1B7-H1 AntigenIBA
03/2022
1Heroin (Diamorphine)IBA
02/2022
1TroponinIBA
01/2022
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1mRNA VaccinesIBA
01/2022
1Insulin (Novolin)FDA Link
11/2021
1HLA-B Antigens (HLA-B)IBA
10/2021
1Asparaginase (Elspar)FDA Link
10/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2021
1PotassiumIBA
04/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2021
1BilirubinIBA
04/2021
1Troponin IIBA
04/2021
1Alanine Transaminase (SGPT)IBA
04/2021
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2021
1fibrin fragment D (D-dimer)IBA
04/2021
1Urea (Carbamide)FDA LinkGeneric
04/2021
1C-Reactive ProteinIBA
04/2021
1Oxygen (Dioxygen)IBA
04/2021
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2021
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2021
1Blood Glucose (Blood Sugar)IBA
01/2021
1LDL CholesterolIBA
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1AnticoagulantsIBA
01/2021

Therapy/Procedure

4Therapeutics
02/2022 - 01/2015
1Radiotherapy
05/2022
1Drug Therapy (Chemotherapy)
05/2022
1Antibiotic Prophylaxis
10/2021
1Critical Care (Surgical Intensive Care)
01/2021